Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report

BACKGROUND: Immune checkpoint inhibitors deeply modified metastatic renal cell carcinoma’s management, and confront us to adverse events that we were not used to with conventional anti-cancer therapies. We report the case of a patient who received nivolumab as second-line treatment of a metastatic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Mari, Roxane, Guerin, Mathilde, Vicier, Cécile, Walz, Jochen, Bonnet, Nathalie, Pignot, Géraldine, Gravis, Gwenaelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524245/
https://www.ncbi.nlm.nih.gov/pubmed/36189265
http://dx.doi.org/10.3389/fimmu.2022.984132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524245/
https://www.ncbi.nlm.nih.gov/pubmed/36189265
http://dx.doi.org/10.3389/fimmu.2022.984132

Ejemplares similares